Ishwaria Subbiah named executive director for cancer care equity and professional wellness at Sarah Cannon Research Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Ishwaria Subbiah was named executive director of cancer care equity and professional wellness at Sarah Cannon Research Institute. In this role, Subbiah will focus on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over 1,300 physicians at over 250 locations in 24 states across the U.S. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents


Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, or anything other than straight and cisgender experience more chronic health conditions, disabilities, and other physical and cognitive limitations than non-LGBTQ+ cancer survivors; however, the prevalence of most conditions was highest among transgender or gender non-conforming individuals, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
Friends of Cancer Research characterized postmarketing requirements and commitments over the last decade. The perspective article, titled “An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials,” provides insights into FDA’s expectations for representation of race and ethnicity in oncology clinical trials.